Metformin and the incidence of cancer in patients with diabetes: a nested case-control study.
作者信息
Wang Shu-Yi, Chuang Chieh-Sen, Muo Chih-Hsin, Tu Shih-Te, Lin Ming-Chia, Sung Fung-Chang, Kao Chia-Hung
出版信息
Diabetes Care. 2013 Sep;36(9):e155-6. doi: 10.2337/dc13-0708.
Abstract
摘要
相似文献
1
Metformin and the incidence of cancer in patients with diabetes: a nested case-control study.二甲双胍与糖尿病患者的癌症发病率：一项巢式病例对照研究。
Diabetes Care. 2013 Sep;36(9):e155-6. doi: 10.2337/dc13-0708.
2
Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research.二甲双胍、癌症、复杂事物以及流行病学在病因学研究中的作用。
Diabetes Care. 2009 Sep;32(9):1748-50. doi: 10.2337/dc09-1183.
3
Comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129.评论：斯米乔夫斯基等人。2型糖尿病患者使用二甲双胍与肺癌发病率。《糖尿病护理》2013年；36:124 - 129。
Diabetes Care. 2013 Mar;36(3):e40. doi: 10.2337/dc12-1978.
4
Response to comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129.对关于Smiechowski等人的评论的回应：2型糖尿病患者使用二甲双胍与肺癌发病率。《糖尿病护理》2013年；36:124 - 129。
Diabetes Care. 2013 Mar;36(3):e41. doi: 10.2337/dc12-2262.
5
Metformin and colorectal cancer risk in diabetic patients.二甲双胍与糖尿病患者的结直肠癌风险
Diabetes Care. 2011 Oct;34(10):2336-7. doi: 10.2337/dc11-1447.
6
Links among type 2 diabetes, cancer and metformin use: what have we learned?2型糖尿病、癌症与二甲双胍使用之间的联系：我们了解到了什么？
Diabetes Res Clin Pract. 2012 Aug;97(2):169-71. doi: 10.1016/j.diabres.2012.03.014. Epub 2012 Apr 10.
7
RE: Association of metformin use and cancer incidence: a systematic review and meta-analysis.关于：二甲双胍使用与癌症发病率的关联：一项系统评价和荟萃分析。
J Natl Cancer Inst. 2024 Aug 1;116(8):1399-1400. doi: 10.1093/jnci/djae132.
8
Metformin and cancer occurrence in insulin-treated type 2 diabetic patients.二甲双胍与胰岛素治疗的 2 型糖尿病患者癌症发病风险。
Diabetes Care. 2011 Jan;34(1):129-31. doi: 10.2337/dc10-1287. Epub 2010 Oct 27.
9
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.二甲双胍的使用与 2 型糖尿病患者肺癌的发生。
Diabetes Care. 2013 Jan;36(1):124-9. doi: 10.2337/dc12-0740. Epub 2012 Aug 24.
10
Metformin and cancer.二甲双胍与癌症。
Eur J Pharmacol. 2013 Apr 5;705(1-3):96-108. doi: 10.1016/j.ejphar.2013.02.038. Epub 2013 Mar 13.
引用本文的文献
1
The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis.二甲双胍的使用与糖尿病患者胰腺癌风险的关系：系统评价和荟萃分析。
BMC Gastroenterol. 2023 Feb 24;23(1):50. doi: 10.1186/s12876-023-02671-0.
2
Prostate Cancer Energetics and Biosynthesis.前列腺癌的能量学和生物合成。
Adv Exp Med Biol. 2019;1210:185-237. doi: 10.1007/978-3-030-32656-2_10.
3
Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis.接受根治性切除的糖尿病肝细胞癌患者使用二甲双胍的生存优势：一项倾向评分匹配分析
Eur J Gastroenterol Hepatol. 2020 Aug;32(8):1030-1035. doi: 10.1097/MEG.0000000000001610.
4
Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.二甲双胍在糖尿病患者中的应用与肺癌风险：系统评价和荟萃分析。
Dis Markers. 2019 Feb 10;2019:6230162. doi: 10.1155/2019/6230162. eCollection 2019.
5
The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.糖尿病患者使用二甲双胍与结直肠癌生存率之间的关联：一项更新的荟萃分析。
Chronic Dis Transl Med. 2017 Jul 13;3(3):169-175. doi: 10.1016/j.cdtm.2017.06.001. eCollection 2017 Sep.
6
Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients.关于使用二甲双胍降低糖尿病患者肝癌风险的研究的荟萃分析。
Medicine (Baltimore). 2017 May;96(19):e6888. doi: 10.1097/MD.0000000000006888.
7
A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.一个关于 AMPK 在前列腺癌中的调控、作用和靶向的时空假说。
Nat Rev Urol. 2017 Mar;14(3):164-180. doi: 10.1038/nrurol.2016.272. Epub 2017 Feb 1.
8
Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.二甲双胍与2型糖尿病中的癌症：一项系统评价与全面偏倚评估
Int J Epidemiol. 2017 Apr 1;46(2):728-744. doi: 10.1093/ije/dyw275.
9
Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.糖尿病药物的比较安全性与浸润性乳腺癌发病风险：一项基于人群的队列研究。
Cancer Causes Control. 2016 May;27(5):709-20. doi: 10.1007/s10552-016-0744-3. Epub 2016 Apr 6.
10
Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.二甲双胍与结直肠癌风险略有降低及糖尿病患者适度生存获益相关：一项荟萃分析。
Medicine (Baltimore). 2016 Feb;95(7):e2749. doi: 10.1097/MD.0000000000002749.
本文引用的文献
1
Metformin does not alter the risk of lung cancer: a case-control analysis.二甲双胍不会增加肺癌风险：病例对照分析。
Lung Cancer. 2012 Nov;78(2):133-7. doi: 10.1016/j.lungcan.2012.08.010. Epub 2012 Sep 7.
2
Investigating metformin for cancer prevention and treatment: the end of the beginning.研究二甲双胍预防和治疗癌症：开端的结束。
Cancer Discov. 2012 Sep;2(9):778-90. doi: 10.1158/2159-8290.CD-12-0263. Epub 2012 Aug 27.
3
The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.2型糖尿病及降糖治疗对台湾地区癌症风险的影响。
Exp Diabetes Res. 2012;2012:413782. doi: 10.1155/2012/413782. Epub 2012 Jun 5.
4
Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.使用二甲双胍与结直肠癌风险降低无关：病例对照分析。
Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):280-6. doi: 10.1158/1055-9965.EPI-11-0992-T. Epub 2011 Dec 16.
5
Metformin and reduced risk of cancer in diabetic patients.二甲双胍与糖尿病患者癌症风险降低
BMJ. 2005 Jun 4;330(7503):1304-5. doi: 10.1136/bmj.38415.708634.F7. Epub 2005 Apr 22.
Zotero 插件